NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

flipper44,

I agree that to Linda an update about Edens might have seemed like a distraction before the MAA application was submitted. However this is a key point of interest to investors as one of the last big runs was based on manufacting expectations with the acquisition of Flaskworks. Dr. Bosch also gave an update on manufacturing at the industry expert theater presentation in 2022 then Linda commented in December of that year at the ASM. Seems to me they were setting up expectations for additional updates which have not come. This gave additional ammo to bears and they have used this and delays to submission to their advantage.
The value driver for this treatment is not only the ability to lead towards a cure but also the ability to reach the masses and contol costs sooner rather than later. This is what Edens represents. When analysts and investors see bottlenecks they see limits in value. When bottlenecks disappear they see rising value. If this is all part of the MAA package then the market gets a big surprise and so do the shorts. Best wishes.